Alaunos Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $4 | $1 | $1 |
Gross Profit | 3 | -1 | ||
EBITDA | -1,127 | -1,128 | -1,680 | |
EBIT | -1,150 | -1,129 | -1,682 | |
Net Income | -1,127 | -1,129 | -1,682 | -7,843 |
Net Change In Cash | 0 | 4 | 1 | 1 |
Free Cash Flow | 28,897 | -1,681 | -1,917 | -7,385 |
Cash | 1,683 | 2,463 | 4,144 | 6,062 |
Basic Shares | 1,601 | 1,601 | 1,601 | 1,601 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $5 | $2,922 | $398 | $0 |
Gross Profit | -4,798 | 163 | -342 | -1,128 |
EBITDA | -30,904 | -31,817 | -74,972 | -79,233 |
EBIT | -33,219 | -34,576 | -77,569 | -80,361 |
Net Income | -35,140 | -37,597 | -76,894 | -78,848 |
Net Change In Cash | 5 | 2,922 | 398 | 0 |
Cost of Revenue | -23,058 | |||
Free Cash Flow | -30,339 | -29,448 | -64,791 | -66,791 |
Cash | 6,062 | 39,058 | 76,054 | 115,069 |
Basic Shares | 1,599 | 1,447 | 1,429 | 1,397 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.70 |
2024-06-30 | -$0.70 |
2024-03-31 | -$0.49 |
2023-12-31 | -$0.49 |
